Prediction Market Platforms Face Legal Crackdown from 16 States As AI Costs Surge Indian Enterprises Increasingly Adopt Smaller Language Models Disneys The Mandalorian and Grogu Opens to 82 Million Weakest Star Wars Debut Yet SpaceX Successfully Launches Starship V3 the Most Powerful Rocket Ever Built DeepSeek Selloff Panic May Be Overblown for AI Leaders Nvidia and Broadcom SpaceXs Path to Nasdaq Listing Highlights Starlinks Central Role in Growth and Profitability SSD Q1 2026 Earnings EPS Surpasses Estimates by 1285 as Structural Products Demand Holds Steady Dianthus Therapeutics Q1 2026 Earnings EPS Beat Amid PreRevenue Stage Hecla Mining Q1 2026 Earnings EPS Falls Short of Expectations Amid Cost Pressures Arteris Inc AIP Q1 2026 Earnings Narrower Loss Drives Optimistic Start to Fiscal Year SNDX Q1 2026 Earnings Narrowed Loss Surprises as Pipeline Progress Continues Centerra Gold Q1 2026 Earnings EPS Misses Estimates Amid Operational Headwinds Applied Industrial Technologies AIT Holds Steady Near MidRange as Volume Remains Modest SAJ Notes Hold Steady at 254 Yield Advantage and Key Technical Levels in Focus Enanta Pharmaceuticals ENTA Edges Higher Testing Resistance Near 1465 Wingstop Inc WING Rallies 585 as Shares Test Key Resistance Yatra Online YTRA Hovers Near Support as Momentum Remains Tepid SpaceXs Path to Nasdaq Listing Highlights Starlinks Central Role in Growth and Profitability PRCT Q1 2026 Earnings EPS Narrowly Beats Estimates as Stock Slips VNET Group Jumps 398 Approaching Key Resistance at 1042 SVRA Q1 2026 Earnings EPS Misses Estimates as PreRevenue Biotech Continues Development VNCE Q1 2026 Earnings Massive EPS Beat Surprises Market Despite Revenue Gap OLPX Q1 2026 Earnings EPS Surprise of 7094 Despite Revenue Uncertainties COE Q3 2025 Earnings EPS of 074 Reflects Ongoing Challenges Amid Revenue Disclosure Gap VOYA Q1 2026 Earnings EPS Surpasses Estimates by 8 Amid Solid Underwriting and Fee Income FGN Q1 2026 Earnings EPS Misses Analyst Estimates Amid Market Volatility Design Therapeutics Inc DSGN Q1 2026 Earnings NarrowerThanExpected Loss Highlights Progress in Gene Therapy Pipeline